Aurobindo, Cadila, UPL in fray to acquire bankrupt Sterling Biotech
Aurobindo Pharma, Cadila Healthcare and UPL are among five companies in the race to acquire bankrupt Sterling Biotech through the liquidation process.
Want to receive such news items in your inbox? Click Here to sign up for a trial.